The increasingly acrimonious battle between Endurance Specialty and Aspen Insurance – sparked by an unsolicited $3.2 billion bid for Aspen by Endurance – took a new twist late last week when Aspen moved to block the bid through a shareholders’ rights plan, which Endurance described as a “poison pill”.
The rest of this article is locked. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, and all the other content. Please use this link and follow the steps.
To take out a free two week trial, use the same link but select the 'trial' option in the dropdown box.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Elliot at firstname.lastname@example.org
Aspen Insurance, Endurance Specialty, Shareholders' Rights Plan, Michael McGuire